We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
-14.55%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$10.7B
AUM Growth
-$2.15B
Cap. Flow
-$3.44M
Cap. Flow %
-0.03%
Top 10 Hldgs %
21.09%
Holding
3,353
New
293
Increased
1,755
Reduced
968
Closed
330

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$15.9M
2
WBD icon
Warner Bros
WBD
+$10.1M
3
ABNB icon
Airbnb
ABNB
+$5.36M
4
KDP icon
Keurig Dr Pepper
KDP
+$4.87M
5
VICI icon
VICI Properties
VICI
+$4.05M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$23M
2
MSFT icon
Microsoft
MSFT
+$19.1M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$12.1M
4
META icon
Meta Platforms (Facebook)
META
+$11.3M
5
T icon
AT&T
T
+$11M

Sector Composition

Rank Sector Weight
1 Technology 22.95%
2 Healthcare 14.35%
3 Financials 13.33%
4 Consumer Discretionary 10.83%
5 Industrials 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSHA icon
3201
Taysha Gene Therapies
TSHA
$1.59B
-3,535
Closed -$23K
TX icon
3202
Ternium
TX
$9.37B
-229
Closed -$10K
TXMD icon
3203
TherapeuticsMD
TXMD
$24M
-1,270
Closed -$24K
UAVS icon
3204
AgEagle Aerial Systems
UAVS
$41.1M
-10
Closed -$12K
URGN icon
3205
UroGen Pharma
URGN
$2.02B
-2,960
Closed -$26K
VATE icon
3206
INNOVATE Corp
VATE
$116M
-573
Closed -$21K
VHC icon
3207
VirnetX Holding Corp
VHC
$51M
-382
Closed -$12K
VIGL
3208
DELISTED
Vigil Neuroscience
VIGL
-2,451
Closed -$17K
VKTX icon
3209
Viking Therapeutics
VKTX
$4.05B
-8,272
Closed -$25K
VMD icon
3210
Viemed Healthcare
VMD
$465M
-4,543
Closed -$23K
VOR icon
3211
Vor Biopharma
VOR
$1.05B
-119
Closed -$14K
VRA icon
3212
Vera Bradley
VRA
$106M
-11,436
Closed -$88K
VRCA icon
3213
Verrica Pharmaceuticals
VRCA
$91.9M
-213
Closed -$17K
VRM icon
3214
Vroom Inc
VRM
$37.5M
-275
Closed -$59K
VSTM icon
3215
Verastem
VSTM
$534M
-2,346
Closed -$40K
WLFC icon
3216
Willis Lease Finance
WLFC
$1.68B
-1,068
Closed -$11K
WVE icon
3217
Wave Life Sciences
WVE
$1.14B
-7,218
Closed -$14K
XBIT icon
3218
XBiotech
XBIT
$68.9M
-1,842
Closed -$16K
XGN icon
3219
Exagen
XGN
$106M
-1,395
Closed -$11K
XLO icon
3220
Xilio Therapeutics
XLO
$59.8M
-77
Closed -$8K
XOMA
3221
DELISTED
Xoma
XOMA
-745
Closed -$21K
YUMC icon
3222
Yum China
YUMC
$15.3B
-42,884
Closed -$1.78M
ZVIA icon
3223
Zevia
ZVIA
$113M
-1,546
Closed -$7K
ZVRA icon
3224
Zevra Therapeutics
ZVRA
$574M
-4,181
Closed -$21K
LENZ
3225
LENZ Therapeutics
LENZ
$179M
-597
Closed -$21K

Similar funds

Amalgamated Bank's Q2 2022 Portfolio in Review

As of Q2 2022, Amalgamated Bank held 3,353 positions worth $10.7B, down 17% from $12.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Amalgamated Bank's Q2 2022 filing shows 293 new, 1,755 increased, 968 reduced and 330 closed positions. Its largest new stake was Airbnb: 41,174 shares worth $3.67M. The largest sale was Apple, an estimated $23M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Amalgamated Bank's largest Q2 2022 buy was Airbnb: 41,174 shares worth $3.67M.
  • Amalgamated Bank added most to Linde in Q2 2022, an estimated $15.9M increase.
  • Amalgamated Bank's biggest Q2 2022 reduction was Apple, cutting an estimated $23M.
  • Amalgamated Bank fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $8.35M.
  • Amalgamated Bank's ten largest holdings make up 21% of its $10.7B portfolio in Q2 2022.
  • Amalgamated Bank opened 293 new positions and closed 330 in Q2 2022.
  • Amalgamated Bank's portfolio value fell 17% quarter-over-quarter to $10.7B.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.